Allan Shaw, Director at Akari Therapeutics, holds 0.00 shares in Onconetix (Ticker: ONCO), holds 33.53K shares in Akari Therapeutics (Ticker: AKTX), holds ― shares in CalciMedica (Ticker: CALC). Most recently, Allan Shaw Bought ― shares of Onconetix on Aug 23, 2022 for an estimated value of 296.36.